Human Brain-cancer Patients Set to Receive Cancer Drug in Clinical Trials

News   Nov 28, 2017 | Original story from University of Illinois

 
Human Brain-cancer Patients Set to Receive Cancer Drug in Clinical Trials

Pretzel's brain tumor shrank more than 40 percent after treatment with PAC-1 in a clinical trial for dogs with glioma, a brain cancer very similar to glioblastoma in humans. Credit: Photo courtesy Tim Fan

 
 
 

RELATED ARTICLES

First Detailed Structure of Telomerase Revealed

News

Over 30 years after its discovery, the detailed molecular structure of the longevity protein telomerase has been revealed, which may have implications for cancer treatment and bone marrow transplants.

READ MORE

Chronic Wasting Disease Didn't Cross Into Primates

News

Chronic wasting disease did not cross the species barrier to infect cynomolgus macaque monkeys during a lengthy investigation exploring risks to humans.

READ MORE

Investigating Inflammasomes Implicated in Diabetic Retinopathy

News

Team of researchers employ mouse model exhibiting diabetic retinopathy symptoms that could lead to future translational research studies.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE